SI0656014T1 - Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition - Google Patents

Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition

Info

Publication number
SI0656014T1
SI0656014T1 SI9430453T SI9430453T SI0656014T1 SI 0656014 T1 SI0656014 T1 SI 0656014T1 SI 9430453 T SI9430453 T SI 9430453T SI 9430453 T SI9430453 T SI 9430453T SI 0656014 T1 SI0656014 T1 SI 0656014T1
Authority
SI
Slovenia
Prior art keywords
protein
purification
pharmaceutical composition
reagent kit
streptococcus
Prior art date
Application number
SI9430453T
Other languages
English (en)
Slovenian (sl)
Inventor
Gunnar Lindahl
Margaretha Stalhammar-Carlemalm
Lars Stenberg
Original Assignee
Gunnar Lindahl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gunnar Lindahl filed Critical Gunnar Lindahl
Publication of SI0656014T1 publication Critical patent/SI0656014T1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/09Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/825Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SI9430453T 1993-03-19 1994-03-21 Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition SI0656014T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9300234 1993-03-19
PCT/SE1994/000246 WO1994021685A1 (en) 1993-03-19 1994-03-21 Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition
EP94911348A EP0656014B1 (en) 1993-03-19 1994-03-21 Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition

Publications (1)

Publication Number Publication Date
SI0656014T1 true SI0656014T1 (en) 2003-12-31

Family

ID=20388669

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9430453T SI0656014T1 (en) 1993-03-19 1994-03-21 Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition

Country Status (18)

Country Link
US (1) US5869064A (ja)
EP (1) EP0656014B1 (ja)
JP (1) JP3976334B2 (ja)
KR (1) KR100331358B1 (ja)
CN (1) CN1046291C (ja)
AT (1) ATE240351T1 (ja)
CA (1) CA2158658A1 (ja)
DE (1) DE69432658T2 (ja)
DK (1) DK0656014T3 (ja)
ES (1) ES2194024T3 (ja)
HK (1) HK1008825A1 (ja)
HU (1) HU217582B (ja)
NZ (1) NZ263275A (ja)
PT (1) PT656014E (ja)
SG (1) SG47049A1 (ja)
SI (1) SI0656014T1 (ja)
WO (1) WO1994021685A1 (ja)
ZA (1) ZA941958B (ja)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015889A (en) * 1993-03-19 2000-01-18 Gunnar Lindahl Protein rib, a cell surface protein that confers immunity to many strains of the group B streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition
TR200002437T2 (tr) 1998-02-20 2000-11-21 Biochem Pharma Inc. B grubu streptococcus antijenleri.
PT1141308E (pt) * 1998-12-22 2007-05-31 Microscience Ltd Ptroteínas de streptococcus do grupo b e sua utilização
US7217415B1 (en) * 1998-12-22 2007-05-15 Emergent Product Development Uk Limited NADP-dependent glyceraldehyde-3-phosphate dehydrogenase for therapeutic use
US6890539B2 (en) 1998-12-22 2005-05-10 Microscience, Ltd. Genes and proteins, and their use
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
WO2000039299A2 (en) * 1998-12-23 2000-07-06 Shire Biochem Inc. Streptococcus antigens
GB9910375D0 (en) 1999-05-05 1999-06-30 Lindahl Gunnar Vaccine composition
DE60221126T2 (de) * 2001-05-31 2008-03-13 Fuso Pharmaceutical Industries, Ltd. Verbessertes verfahren zum nachweis und zur identifizierung eines eine infektion verursachenden mikroorganismus
EP1795594A3 (en) * 2001-05-31 2008-04-02 Fuso Pharmaceutical Industries, Ltd. Method of evaluating the function of phagocyte and utilization thereof
WO2003068813A2 (en) * 2002-02-11 2003-08-21 Shire Biochem Inc Group b streptococcus antigen
JP2008530021A (ja) * 2005-02-08 2008-08-07 アイディー バイオメディカル コーポレイション オブ ケベック シー.オー.ビー. アズ グラクソスミスクライン バイオロジカルズ ノース アメリカ 医薬組成物
CA2684494C (en) 2007-04-16 2016-07-05 Lunds Universitets Utvecklingsaktiebolag Fusion protein capable of eliciting protective immunity against group b streptococcus
WO2017068112A1 (en) 2015-10-21 2017-04-27 Minervax Aps Immunogenic fusion protein
US10888610B2 (en) 2015-12-30 2021-01-12 Minerv Ax Aps Immunogenic complex for eliciting protective immunity against group b streptococcus
CA3066020A1 (en) 2017-06-16 2018-12-20 Glaxosmithkline Biologicals Sa Method of treatment
BR112022008761A2 (pt) 2019-11-22 2022-07-26 Glaxosmithkline Biologicals Sa Dosagem e administração de uma vacina de glicoconjugado de sacarídeo
EP4066854A1 (en) 2021-03-29 2022-10-05 MinervaX Immunogenic fusion protein

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302386A (en) * 1986-04-16 1994-04-12 Brigham And Women's Hospital, Inc. Bacterial antigens, antibodies, vaccines and methods of manufacture
US4772584A (en) * 1986-05-23 1988-09-20 Cleary Paul P Inhibitor of C5a-mediated chemotaxis
EP0367890A1 (en) * 1988-11-11 1990-05-16 HighTech Receptor AB Protein Arp, with immunoglobulin A binding activity, cloning and expression thereof
IL95578A (en) * 1989-09-15 1998-08-16 Gen Hospital Corp A vaccine made from polysaccharide and protein
US5648241A (en) * 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
CA2103551A1 (en) * 1991-03-29 1992-09-30 Ervin Faulmann Method for production of an iga binding protein derived from group b streptococci

Also Published As

Publication number Publication date
EP0656014B1 (en) 2003-05-14
KR960701096A (ko) 1996-02-24
ZA941958B (en) 1995-01-27
HU9501993D0 (en) 1995-08-28
DK0656014T3 (da) 2003-08-11
KR100331358B1 (ko) 2002-08-13
CN1119442A (zh) 1996-03-27
SG47049A1 (en) 1998-03-20
EP0656014A1 (en) 1995-06-07
ATE240351T1 (de) 2003-05-15
US5869064A (en) 1999-02-09
NZ263275A (en) 1997-07-27
CN1046291C (zh) 1999-11-10
WO1994021685A1 (en) 1994-09-29
HUT72841A (en) 1996-05-28
JP3976334B2 (ja) 2007-09-19
AU681130B2 (en) 1997-08-21
CA2158658A1 (en) 1994-09-29
DE69432658D1 (de) 2003-06-18
DE69432658T2 (de) 2004-04-08
HK1008825A1 (en) 1999-05-21
HU217582B (hu) 2000-02-28
PT656014E (pt) 2003-09-30
AU6389194A (en) 1994-10-11
JPH09500092A (ja) 1997-01-07
ES2194024T3 (es) 2003-11-16

Similar Documents

Publication Publication Date Title
HK1008825A1 (en) Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition
DE262192T1 (de) Verfahren und mittel zur herstellung eines proteins mit dergleichen igg-spezifizitaet wie protein g.
ES8506348A1 (es) Procedimiento para producir la subunidad b de la toxina del colera
ATE323721T1 (de) Cholin-bindendes protein, welches als gegen pneumokokken gerichtetes vakzin verwendet wird
AU1672388A (en) Expression of human proapolipoprotein a-i
MXPA03009294A (es) Proteinas de superficie de streptococcus pyogenes.
NZ296748A (en) Peripheral nervous system specific sodium channel proteins, DNA coding therefor, compositions and methods
WO1999015666A3 (en) Macrophage derived chemokine (mdc), mdc analogs, mdc inhibitor sustances, and uses thereof
WO1998021337A3 (en) C3 BINDING PROTEIN OF $i(STREPTOCOCCUS PNEUMONIAE)
ZA933216B (en) Recombinant DNA molecules encoding aminopeptidas enzymes and their use in the preparation of vaccines against helminth infections
AU8127494A (en) Chimeric proteins comprising borrelia polypeptides: uses therefor
NZ500540A (en) Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae
CA2093427A1 (en) Molecular clones of hiv-1 and uses thereof
AU7247891A (en) Purified myeloblastin, nucleic acid molecule encoding same, and uses thereof
GB9409985D0 (en) Vaccine against mycobacterial infections
WO1996008569A3 (en) Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof
HUP0104825A2 (hu) Gének, fehérjék és alkalmazásuk
IT1260153B (it) Individuazione di un frammento di dna codificante l'enzima acido ialuronico sintetasi (has) e della sua sequenza nucleotidica
Schmidt et al. Mitogenicity of M5 protein extracted from Streptococcus pyogenes cells is due to streptococcal pyrogenic exotoxin C and mitogenic factor MF
BR9908476A (pt) Peptìdeo, composição terapêutica, e, processo para conferir imunidade protetora a um paciente, contra a infecção de s. pneumoniae
WO1997035982A3 (en) Monocyte chemotactic protein-5 materials and methods
NZ233672A (en) Alpha amylase-pullulanase enzyme produced by recombinant techniques and its dna coding sequence
AU1540795A (en) Diagnosis and treatment of infections due to streptococci and enterococci
EP0866128A3 (en) Recombinant ricin toxin
SE9301207D0 (sv) Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition